Ibrutinib in primary central nervous system diffuse large B-cell lymphoma
The standard regimen for the treatment of newly diagnosed primary CNS lymphoma (PCNSL) remains regimens that contain high-dose methotrexate (MTX). While these regimens can provide control for some patients, there is a dearth of options for the treatment of patients with PCNSL who cannot tolerate MTX...
Salvato in:
| Autori principali: | , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Taylor & Francis Group
2020-03-01
|
| Serie: | CNS Oncology |
| Soggetti: | |
| Accesso online: | https://www.futuremedicine.com/doi/10.2217/cns-2019-0022 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|